| Reviewer | Recommendation |
| IPOWatch | May Apply |
| Dilip Davda | Not Rated |
The firm designs and manufactures lightweight, affordable lab-grown diamond-studded gold jewellery catering to growing demand for affordable luxury and daily-wear jewellery. Its lab-grown diamonds are created in laboratories using advanced technological processes.
For medium-term investment, this IPO might be a good fit. Overall, investors should carefully evaluate the company’s fundamentals, strengths, risks, and growth prospects before deciding whether to invest.
Strengths:
- The firm is supported by its own manufacturing facilities, has its own design team, and uses technology to design high-quality and innovative jewellery.
- The company is positioned to benefit from the growth of lab-grown diamond jewellery.
- The firm is backed by 122 skilled in-house karigars, enabling quality work while reducing dependency on third-party workers.
- Its Revenue grew from ₹53.66 crore in FY2024 to ₹202.89 crore in FY2026, with a 94.46% CAGR. PAT rose from ₹4.02 crore to ₹22.32 crore, while EBITDA increased from ₹5.48 crore to ₹30.97 crore, showcasing strong financial performance.
Weaknesses:
- In FY26, around 55.49% of its revenue comes from its top 10 B2B customers. Loss of any of the top customers can adversely impact its business and cash flow.
- About 85.03% of the company’s revenue comes from a limited number of states in India, particularly Gujarat, Karnataka, Telangana, Tamil Nadu, and Maharashtra. Loss of any customers from these states or any negative developments in these regions can badly affect the business condition.
- The company’s 86.16% of raw materials come from the top 10 suppliers in FY26. Any interruption in raw material supply, or any supplier deciding to stop supplying raw materials, can negatively affect the business and financial condition.
- Nityas Gems and Jewellery manufacturing operations are concentrated at a single facility in Surat, Gujarat. Any slowdown, shutdown, interruption, or inability to maintain the quality of its products can badly affect the overall business, financial condition, and cash flow.
Disclaimer
Investors are advised to make their own decisions and apply entirely at their own risk. This article is written using information from the company’s RHP (Red Herring Prospectus) data and online sources. If you have any queries, kindly contact the IPO Watch Team.
